Literature DB >> 21330329

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype.

Bin Xie, Megan Othus, Bruno C Medeiros, Min Fang, Frederick R Appelbaum, Elihu H Estey.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21330329      PMCID： PMC3069244          DOI： 10.3324/haematol.2010.037838

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Identification of a group of AML/MDS patients with a relatively favorable prognosis who have chromosome 5 and/or 7 abnormalities.

Authors:  E H Estey; S Pierce; M J Keating
Journal:  Haematologica       Date:  2000-03       Impact factor: 9.941

2.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.

Authors:  Bruno C Medeiros; Megan Othus; Min Fang; Diane Roulston; Frederick R Appelbaum
Journal:  Blood       Date:  2010-06-18       Impact factor: 22.113

Review 3.  Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia.

Authors:  Krzysztof Mrózek; Clara D Bloomfield
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

4.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.

Authors:  Dimitri A Breems; Wim L J Van Putten; Georgine E De Greef; Shama L Van Zelderen-Bhola; Klasien B J Gerssen-Schoorl; Clemens H M Mellink; Aggie Nieuwint; Martine Jotterand; Anne Hagemeijer; H Berna Beverloo; Bob Löwenberg
Journal:  J Clin Oncol       Date:  2008-08-11       Impact factor: 44.544

Review 5.  Cytogenetics in acute leukemia.

Authors:  Krzysztof Mrózek; Nyla A Heerema; Clara D Bloomfield
Journal:  Blood Rev       Date:  2004-06       Impact factor: 8.250

6.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

Authors:  D Grimwade; H Walker; F Oliver; K Wheatley; C Harrison; G Harrison; J Rees; I Hann; R Stevens; A Burnett; A Goldstone
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

7.  Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

Authors:  John C Byrd; Krzysztof Mrózek; Richard K Dodge; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Shivanand R Patil; Kathleen W Rao; Michael S Watson; Prasad R K Koduru; Joseph O Moore; Richard M Stone; Robert J Mayer; Eric J Feldman; Frederick R Davey; Charles A Schiffer; Richard A Larson; Clara D Bloomfield
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113
  7 in total
  5 in total

1.  Prognostic impact of residual normal metaphases in acute myeloid leukemia with t(8;21)(q22;q22).

Authors:  Lijun Wen; Jing Xia; Qinrong Wang; Hong Yao; Jundan Xie; Jinlan Pan; Yongquan Xue; Depei Wu; Suning Chen
Journal:  Int J Hematol       Date:  2015-06-04       Impact factor: 2.490

2.  Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum.

Authors:  Dimitri A Breems; Bob Löwenberg
Journal:  Haematologica       Date:  2011-04       Impact factor: 9.941

3.  Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.

Authors:  Bruno C Medeiros; Megan Othus; Min Fang; Frederick R Appelbaum; Harry P Erba
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

4.  Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

Authors:  Jae-Ho Yoon; Hee-Je Kim; Seung-Hwan Shin; Seung-Ah Yahng; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chong-Won Park
Journal:  Int J Hematol       Date:  2013-04-25       Impact factor: 2.490

5.  Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype.

Authors:  J E Jang; Y H Min; J Yoon; I Kim; J-H Lee; C W Jung; H-J Shin; W S Lee; J H Lee; D-S Hong; H-J Kim; H-J Kim; S Park; K-H Lee; J H Jang; J S Chung; S M Lee; J Park; S K Park; J-S Ahn; W-S Min; J-W Cheong
Journal:  Blood Cancer J       Date:  2015-10-16       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.